Bookmark and Share

Last Minute: "Birmingham explosion: Woman found dead and man seriously hurt - BBC" Mon, 27 Jun 2022 10:10:17 GMT    "Boris Johnson news ? live: PM insists he is ?not worried? by Tory leadership plots - The Independent" Mon, 27 Jun 2022 10:52:48 GMT    "Russia set for first debt default since 1998 as payment deadline passes - Financial Times" Mon, 27 Jun 2022 10:37:16 GMT    "'Dangerous' and violent man jailed for 'most appalling campaign of abuse' court had ever seen - Sky News" Mon, 27 Jun 2022 06:23:58 GMT    "Barristers walk out of courts in strike over pay - BBC" Mon, 27 Jun 2022 10:35:12 GMT    "Russia faces oil price cap in fresh blow to Kremlin - live updates - The Telegraph" Mon, 27 Jun 2022 10:49:53 GMT    "Stories of children killed in the Troubles to be told to MPs - The Guardian" Mon, 27 Jun 2022 07:00:00 GMT    "Liz Truss: we have a duty to fix the problems of the Northern Ireland protocol - Financial Times" Sun, 26 Jun 2022 11:00:59 GMT    "Furious holidaymakers finally get to Majorca after 43-hour flight delay - ITV News" Mon, 27 Jun 2022 08:27:24 GMT   "Zelenskiy meets G7 leaders as US plans to give air defence system to Ukraine - The Guardian" Mon, 27 Jun 2022 10:23:00 GMT      For more news, click here.

Authentication
       
       
Remember me? 

Fall of
--0.82 (+0.99%) Celgene Corporati - [Ticker: CELG]Chart Celgene Corporati  News Celgene Corporati  Download Historical Prices for Metastock Celgene Corporati and Others  Technical Analysis Celgene Corporati  
Last Trade70.16Last Trade Time2018-11-29 - 00:00:00
Variation--0.82 (+0.99%)Open70.40
High71.03Low68.93
Volume6,015,655Average Volume (3m)0
YieldBid / Ask100.75 x 400 - 100.78 x 100
Former Close70.9852 Week Range[0.00 - 0.00]
PER0.00%EPS0.00
Ex-Dividend DateDividend Payment
Market Capitalization0 1 Year Price-Target0.00
Note: The data may have some minutes of delay.
Watch more quotes

Intraday   5 days   1 month   3 months   6 months   1 year   2 years   5 years   10 years            Use this chart on your website!
Celgene Corporati -  [Ticker: CELG] chart
Change to Celgene Corporati Interactive Technical Analysis Chart

Last 10 Forum Topics about Celgene Corporati:
No topics about Celgene Corporati [CELG] have been found, but a search on the Forum for more topics related to Celgene Corporati is advised.

 News about Celgene Corporati [CELG]:   (ordered by relevance)
Alpha Thalassemia Treatment Market Size, Scope and Forecast | Novartis AG, Celgene Corporation, Bluebird Bio Acceleron Pharma Shire Plc. ? Designer Women  Designer Women Bristol Myers must face $6.4 bln lawsuit over delayed cancer drug  Reuters.com Vasculitis Treatment Market Size, Scope and Forecast | Celgene Corporation, Merck & Co, Novartis AG, F. Hoffmann-La Roche, GlaxoSmithKline plc, Bristol-Myers Squibb Company, RNL BIO Co. Ltd., Teijin Pharma Limited, Anthera Pharmaceuticals Inc.  Designer Women Triple-Negative Breast Cancer Treatment Market Outlook 2022 And Growth By Top KeyPlayers ? Novartis AG, Bristol-Myers Squibb Company, Celgene Corporation, Mylan NV ? Designer Women  Designer Women Protein Kinase C Theta Market worth $7.3 billion by 2027 -AbbVie Inc, Astellas Pharma Inc, Celgene Corp, CompleGen Inc, Takeda Pharmaceutical Co Ltd ? Indian Defence News  Indian Defence News Healthcare Nanotechnology (Nanomedicine) Market Size, Scope and Forecast | Sanofi SA, Pfizer Inc., Celgene Corporation, Luminex Corporation, Taiwan Liposome Company Ltd. And others. ? Designer Women  Designer Women Orphan Drugs Market Size, Scope and Forecast | Celgene Corporation, Hoffmann- La Roche, Bristol-Myers Squibb, Alexion Pharmaceuticals, Inc., Biogen Idec Limited, Novartis AG, Vertex Pharmaceuticals, Inc., Takeda Pharmaceuticals Company Limited ? D  Designer Women Multiple Myeloma Diagnostic Market Size And Forecast to 2028 |Celgene Corporation, Johnson & Johnson, F. Hoffmann-La Roche Ltd, Bristol-Myers Squibb Company, Millennium Pharmaceuticals ? Designer Women  Designer Women Global Bladder Cancer Treatment Drugs Market Business Opportunities and Research 2022-2029 Pfizer, GlaxoSmithKline, Celgene Corporation, Sanofi ? Designer Women  Designer Women Global Mitogen Activated Protein Kinase 8 Market 2022, Competitors- Celgene Corp, Eisai Co Ltd, OPKO Health Inc, Xigen SA ? Indian Defence News  Indian Defence News Cancer mTOR Inhibitors Market Is Expected to Boom | Abraxis BioScience,Adimab,Celgene Corporation,Celator Pharmaceuticals,Eli Lilly,Exelixis  Digital Journal Thyroid Cancer Drugs Market Size, Scope and Forecast | AstraZeneca, Mylan NV, Eisai Co. Ltd., Bristol-Myers Squibb Company, Abbott, Teva Pharmaceutical Industries Ltd, GlaxoSmithKline plc, Jerome Stevens Pharmaceuticals, Baxter, Celgene Corporation.  Designer Women Cancer Biological Therapy Market Size, Scope and Forecast | F. Hoffmann-La Roche AG, Novartis International AG, Merck & Co. Amgen Inc., GlaxoSmithKline Plc, Celgene Corporation. ? Designer Women  Designer Women Cancer Therapeutics Market Size, Scope and Forecast | F. Hoffmann-La Roche AG, Bristol-Myers Squibb Company, AbbVie Johnson & Johnson, Celgene Corporation, Astellas Pharma Pfizer Novartis AG, Merck KGaA, Bayer AG, Takeda Pharmaceutical  Designer Women Triple-Negative Breast Cancer Treatment Market Size 2022 And Analysis By Top KeyPlayers ? Novartis AG, Bristol-Myers Squibb Company, Celgene Corporation, Mylan NV ? Designer Women  Designer Women Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market 2022 With Top Countries Data Analysis, Size, Objectives, Research Methods, Trend, Application, Market, Comparison By Region And Forecast By 2029 ? Indian Defence News  Indian Defence News Scleroderma Therapeutics Market Size, Scope and Forecast | Boehringer Ingelheim International GmbH, Celgene Corp., arGentis Pharmaceuticals, LLC, Kadmon Holdings, Inc., Emerald Health Pharmaceuticals, F. Hoffman La-Roche Ltd., Bristol-Myers Squib  Designer Women Global Angiogenesis Modulators Market 2022 Development Factors ? Celgene Corporation (USA), Eisai (Japan), Amgen Inc. (USA), Genentech Inc. (USA) ? Indian Defence News  Indian Defence News Global Cancer mTOR Inhibitors Market Current Scope 2022 ? Abraxis BioScience, Adimab, Celgene Corporation, Celator Pharmaceuticals ? Designer Women  Designer Women Yersinia Diagnostics Market Outlook: Post Covid-19 Scenario by 2029 | CELGENE CORPORATION, GlaxoSmithKline, Portola Pharmaceuticals ? Indian Defence News  Indian Defence News Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Overview, High Growth Opportunities, Segmentation, Trends By 2022-2028 | Akshaya Bio Inc., OSE Immunotherapeutics, Celgene Corporati? ? Indian Defence News  Indian Defence News Massive Growth of AI in Corporate Banking Market by 2029 | AbbVie, Amgen, Celgene Corporation ? Indian Defence News  Indian Defence News Menopausal Disorder Treatment Market Set to Witness Explosive Growth by 2029 | Amgen Inc., Celgene Corporation, Boehringer Ingelheim GmbH ? Indian Defence News  Indian Defence News US open: Stocks in the green as traders return from Juneteenth break | Financial News  London South East Cancer Nanotherapy Market 2021 Development Plans and Competitors and Key Players-Celgene Corporation, Galen Limited ? Indian Defence News  Indian Defence News Bile Duct Cancer Treatment Market Demand, Recent Developments, Company Profile Analysis, and Growth Opportunities Forecast Report 2022-2029  Digital Journal Global Psoriasis Drugs Market Insights Report 2022, Trends & Opportunities to 2031 ? Designer Women  Designer Women Global Inflammatory Bowel Disease Treatment Industry to 2028 ? Key Drivers, Challenges and Trends by Abbott Laboratories, AbbVie Inc., Agilent Technologies, Inc, Alkem Laboratories Limited ? Designer Women  Designer Women Landos Names Gregory Oakes President and Chief Executive Officer  StreetInsider.com Tyrosine Kinase JAK Inhibitors Market 2022: Industry Trends and Investigation Growth Rate, consumption by Regional data, Product & Application Segmentation, Key Companies and Analysis |CAGR of 50.6% |[Reports Page No 93]  Digital Journal Cancer Immunotherapy Market Research Report By Current and Future Trends, Statistics To 2028 ? Indian Defence News  Indian Defence News LAVA Therapeutics Announces Two Appointments to its Board of Directors  GuruFocus.com What Are The Upcoming Trends In Stem Cell Therapy Market? ? Indian Defence News  Indian Defence News Hemoglobinopathies Drugs Market: 2022 Share, Size, Future Demand, Trends, Region by Forecast to 2030 ? Indian Defence News  Indian Defence News Health News Roundup: Juul's checkered e-cigarette journey cut short by FDA ban; Factbox-Latest on the worldwide spread of the coronavirus and more  Devdiscourse BioMarin Appoints Former CEO of Celgene Corporation, Mark Alles, to Board of Directors  PR Newswire Celgene Must Face Humana Suit on 'Supracompetitive' Drug Prices  Bloomberg Law Follicular Lymphoma Treatment Market to Witness Increased Incremental Dollar Opportunity during the Forecast Period 2020 ? 2028 ? Indian Defence News  Indian Defence News Kessler Topaz Meltzer & Check, LLP Announces Pendency of Class Action on Behalf of Purchasers of Celgene Corporation Common Stock  PR Newswire Bristol-Myers Squibb Completes Acquisition of Celgene, Creating a Leading Biopharma Company  Business Wire Entwistle & Cappucci LLP Files a Securities Class Action Complaint Against Bristol-Myers Squibb Company  Business Wire Mylan's win against Celgene drug-patent claims OK'd by Fed Circ.  Reuters.com Premium Insights on Injection Molding Materials Market 2022-2028 by BASF, ExxonMobil, LyondellBasell, Eastman Chemical Company, Huntsman Corporation, DowDuPont, and more ? Indian Defence News  Indian Defence News Celgene stock surges after ISS Supports Bristol-Myers acquisition.  Barron's TC BioPharm Announces Formation of Scientific Advisory Board with Renowned Cell Therapy Experts  GuruFocus.com Bristol-Myers Squibb to Acquire Celgene to Create a Premier Innovative Biopharma Company  Business Wire Bristol Myers will likely settle the $6.4B Celgene CVR lawsuit at a discount, analyst says. Here's why  FiercePharma Sun Pharma settles patent litigation with Celgene Corporation for cancer drug Revlimid  Economic Times $12 Billion Worldwide Gene Therapy Industry to 2031 - Identify Growth Segments for Investment  GlobeNewswire BRISTOL-MYERS CVR INVESTORS: December 6, 2021 Filing Deadline in Class Action ? Contact Lieff Cabraser  Business Wire Case Summary: Juno Pharmaceuticals v Celgene Corporation  Lexology It had to happen: Ex-Celgene shareholders sue Bristol Myers Squibb for $6.4B in lost CVR cash, claiming 'blatant misconduct'  FiercePharma Adipose Tissue-derived Stem Cell Therapy Market 2022 ? Increasing Demand, Growth Analysis and Future Outlook by AlloCure, Antria, Celgene Corporation ? Designer Women  Designer Women Is It Too Late to Buy Celgene Stock?  The Motley Fool Why Celgene's Beaten Down Stock Can Rise 28%  Investopedia Wellington Management Does Not Support Bristol-Myers Squibb's Acquisition of Celgene Corporation  Business Wire How Celgene's Big Acquisition Could Fire Up Its Stock  Investopedia Editas Medicine and Celgene Corporation Amend Existing Collaboration to Develop and Commercialize Autologous and Allogeneic T Cell Medicines for the Treatment of Cancer and Autoimmune Diseases  GlobeNewswire ServiceNow (NOW) to Replace Celgene (CELG) in the S&P 500; Thermo Fisher Scientific (TMO) Set to Join S&P 100  StreetInsider.com Celgene (CELG) Updates on R&D Deep Dive (Multiple Myeloma) - Slideshow (NASDAQ:CELG)  Seeking Alpha Celgene Strikes Strategic Partnership With Evotec  Investopedia Bristol-Myers/Celgene: Win-Win Merger (NASDAQ:CELG)  Seeking Alpha Bristol-Myers Squibb (BMY) And Celgene (CELG) Merger - Slideshow (NYSE:BMY)  Seeking Alpha Celgene Reports Third Quarter 2019 Operating and Financial Results  Business Wire How a Juno Takeover Could Boost Celgene  Investopedia Kyn Therapeutics Enters into Global Strategic Collaboration with Celgene to Develop Immuno-oncology Therapies  Business Wire Celgene Corporation Announces Appointment of Dr. Alise Reicin to President, Global Clinical Development  Business Wire Is Celgene and Bristol-Myers a Match Made in Heaven or Doomed to Fail?  The Motley Fool Celgene Reports Fourth Quarter and Full-Year 2017 Operating and Financial Results  Business Wire Celgene Stock History: The Biotech's Path to Gigantic Gains  The Motley Fool Jounce Therapeutics Announces Update on Strategic Collaboration with Celgene Corporation  GlobeNewswire Bile Duct Cancer Market Size, Scope and Forecast | F. Hoffmann-La Roche Ltd., Johnson & Johnson, Sanofi, Bayer AG, Celgene Corp, Bristol-Myers Squibb, ConMed Corporation, Pfizer Novartis AG, Merck & Co., Inc. ? Designer Women  Designer Women Celgene Completes Acquisition of Juno Therapeutics, Inc., Advancing Global Leadership in Cellular Immunotherapy  Business Wire Celgene buys EngMab for $600M and will head into clinic next year  FierceBiotech Biotech Celgene Seen Rebounding 10% on Higher Sales  Investopedia Celgene's Next Blockbuster: What You Need to Know  The Motley Fool bluebird bio and Celgene Corporation Enter into Agreement to Co-Develop and Co-Promote Anti-BCMA CAR T Cell Therapy bb2121 in the United States  Business Wire Bristol Myers Is Taking Full Advantage of its Celgene Acquisition  The Motley Fool Is Celgene A Growth Or A Value Stock? (NASDAQ:CELG)  Seeking Alpha Celgene In 2018: A Look At The Long Thesis (NASDAQ:CELG)  Seeking Alpha Celgene to pay $280 million to settle off-label marketing case  Reuters.com Celgene's $13.4 Billion Deal With Amgen Is a Win-Win-Win  The Motley Fool Bristol-Myers Squibb wins antitrust approval to buy Celgene, but must divest psoriasis drug  Reuters.com Former Celgene, Portola Lawyers Land New Big Pharma Roles  Bloomberg Law Acceleron Pharma Announces Global Collaboration with Celgene Corporation on ACE-536 Program  FierceBiotech Celgene plunges 18% after biotech company slashes 2020 guidance; worst drop in 17 years  CNBC Better Buy: Geron vs. Celgene  The Motley Fool Deal of the Year: Bristol-Myers Squibb buys Celgene  BioPharma Dive Celgene to Acquire Delinia, Inc.  Business Wire Celgene's Stock May See More Big Gains Ahead  Investopedia Nearly One Year Post-Celgene: BMS CMO On Pipeline Progress, Clinical Trial Diversity  Scrip Celgene, sold for $74 billion, leaves a legacy of chutzpah in science and drug pricing  STAT Deep Diving Celgene - Early Stages Of A Transition (NASDAQ:CELG)  Seeking Alpha Celgene Gave This Tech Back to Editas Medicine, but It Could Prove Valuable  The Motley Fool Celgene's drug for anemia in beta thalassemia priced at $3441/ 25 mg vial  Reuters.com Celgene Stock Split: Is the Biotech Ready to Split Again?  The Motley Fool Vividion Therapeutics Announces Strategic Research Collaboration with Celgene Corporation to Discover Therapies Against Transformative, First-in-Class Targets  PR Newswire Celgene takes its most aggressive price hikes yet on Revlimid, Pomalyst: analyst  FiercePharma Case summary on the recent Australian pharmaceutical patent litigation - Juno Pharmaceuticals Pty Ltd v Celgene Corporation [2021] FCA 236  Lexology Celgene to buy Juno for $9 billion to boost cancer pipeline  Reuters.com
For more news about Celgene Corporati click here:
Celgene Corporati News
Search the Internet:

Website Width:
Bookmark and Share

 Background image:

Copyright@2010-2022 - TR4DER.com, all rights reserved.
Investment Forum Stock Quotes Investment News Investment Chat Disclaimer Webmaster Resources